Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
Annette Wong(The University of Sydney), Gopala K. Rangan(Westmead Hospital), Bradley J. Erickson(Mayo Clinic), Philip McCloud(National Council for Palliative Care), Carly Mannix(The University of Sydney), Timothy L. Kline(Mayo Clinic), Marie E. Edwards(Mayo Clinic), Maureen Lonergan(Wollongong Hospital), Kamal Sud(Post Graduate Institute of Medical Education and Research), Susan Coulshed, David W. Johnson(Hennepin County), Sheryl Foster(The University of Sydney), Imad Haloob, Karen Byth(Westmead Hospital), Karthik Kumar(Gosford Hospital), Simon Jiang(Australian National University), Eswari Vliayuri(John Hunter Hospital), Neil Boudville(The University of Western Australia), Vicente E. Torres(Mayo Clinic in Arizona), Anna Rangan(The University of Sydney), Sunil V. Badve(UNSW Sydney), Kirsten Howard(The University of Sydney), Martin Howell(UNSW Sydney), Carmel M. Hawley(The University of Queensland), Mangalee Fernando(UNSW Sydney), Julie Hill, Vincent Lee(The University of Sydney), David C.H. Harris(The University of Sydney), Simon D. Roger(Gosford Hospital), Jessie S. M. Chan(National Council for Palliative Care), Anthony Peduto(Westmead Hospital), Jared J. Grantham(National Institutes of Health), Jun Mai(Liverpool Hospital), Margaret Allman‐Farinelli(The University of Sydney)
Cited by 87
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
|Neuro-Oncology|2015|670